Search Results Search Sort by RelevanceMost Recent Case and Commentary Jul 2003 Drug Company Sponsorship of Clinical Conferences, Commentary 2 Ashley Wazana, MD Virtual Mentor. 2003;5(7):242-246. doi: 10.1001/virtualmentor.2003.5.7.ccas1-0307. Case and Commentary Jul 2003 Clinician and Researcher, Commentary 1 Timothy F. Murphy, PhD Virtual Mentor. 2003;5(7):247-250. doi: 10.1001/virtualmentor.2003.5.7.ccas2-0307. Case and Commentary Jul 2003 Clinician and Researcher, Commentary 2 Matthew Wynia, MD Virtual Mentor. 2003;5(7):251-254. doi: 10.1001/virtualmentor.2003.5.7.ccas2-0307. In the Literature Jun 2003 Assessing Affirmative Action in Medical Schools Michelle Lim Virtual Mentor. 2003;5(6):219-221. doi: 10.1001/virtualmentor.2003.5.6.jdsc3-0306. In the Literature Jul 2003 Financial Conflicts of Interest in Biomedical Research Jeremy Spevick Virtual Mentor. 2003;194-196. doi: 10.1001/virtualmentor.2003.5.7.jdsc1-0307. Medical Education Jun 2003 Grutter v Bollinger Susanna Smith Virtual Mentor. 2003;5(6):208-210. doi: 10.1001/virtualmentor.2003.5.6.medu1-0306. Medical Education Jul 2003 Commercial Support for Continuing Medical Education Murray Kopelow, MD Virtual Mentor. 2003;5(7):255-259. doi: 10.1001/virtualmentor.2003.5.7.medu1-0307. Policy Forum Jul 2003 Undergraduate and Graduate Medical Education and the Pharmaceutical Industry Greg E. Manship, MDiv, MA Virtual Mentor. 2003;5(7):268-272. doi: 10.1001/virtualmentor.2003.5.7.pfor1-0307. Policy Forum Jul 2003 The PhRMA Code: A New Roadmap for Industry-Physician Interactions Michael Scott Labson, Esq Virtual Mentor. 2003;5(7):273-275. doi: 10.1001/virtualmentor.2003.5.7.pfor2-0307. In the Literature Dec 2003 Meaningful Assessment of Professional Competence in Medical School Curriculum Jaclyn Halpern, MD Virtual Mentor. 2003;5(12):560-563. doi: 10.1001/virtualmentor.2003.5.12.jdsc1-0312. Pagination First page « First Previous page ‹ Previous … Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Page 10 Page 11 … Next page Next › Last page Last »
Case and Commentary Jul 2003 Drug Company Sponsorship of Clinical Conferences, Commentary 2 Ashley Wazana, MD Virtual Mentor. 2003;5(7):242-246. doi: 10.1001/virtualmentor.2003.5.7.ccas1-0307.
Case and Commentary Jul 2003 Clinician and Researcher, Commentary 1 Timothy F. Murphy, PhD Virtual Mentor. 2003;5(7):247-250. doi: 10.1001/virtualmentor.2003.5.7.ccas2-0307.
Case and Commentary Jul 2003 Clinician and Researcher, Commentary 2 Matthew Wynia, MD Virtual Mentor. 2003;5(7):251-254. doi: 10.1001/virtualmentor.2003.5.7.ccas2-0307.
In the Literature Jun 2003 Assessing Affirmative Action in Medical Schools Michelle Lim Virtual Mentor. 2003;5(6):219-221. doi: 10.1001/virtualmentor.2003.5.6.jdsc3-0306.
In the Literature Jul 2003 Financial Conflicts of Interest in Biomedical Research Jeremy Spevick Virtual Mentor. 2003;194-196. doi: 10.1001/virtualmentor.2003.5.7.jdsc1-0307.
Medical Education Jun 2003 Grutter v Bollinger Susanna Smith Virtual Mentor. 2003;5(6):208-210. doi: 10.1001/virtualmentor.2003.5.6.medu1-0306.
Medical Education Jul 2003 Commercial Support for Continuing Medical Education Murray Kopelow, MD Virtual Mentor. 2003;5(7):255-259. doi: 10.1001/virtualmentor.2003.5.7.medu1-0307.
Policy Forum Jul 2003 Undergraduate and Graduate Medical Education and the Pharmaceutical Industry Greg E. Manship, MDiv, MA Virtual Mentor. 2003;5(7):268-272. doi: 10.1001/virtualmentor.2003.5.7.pfor1-0307.
Policy Forum Jul 2003 The PhRMA Code: A New Roadmap for Industry-Physician Interactions Michael Scott Labson, Esq Virtual Mentor. 2003;5(7):273-275. doi: 10.1001/virtualmentor.2003.5.7.pfor2-0307.
In the Literature Dec 2003 Meaningful Assessment of Professional Competence in Medical School Curriculum Jaclyn Halpern, MD Virtual Mentor. 2003;5(12):560-563. doi: 10.1001/virtualmentor.2003.5.12.jdsc1-0312.